Bryan Sands, DO
Dermatology · Waterloo, IANPI 1770548570
Payments from drug & device makers
What this record shows
7 manufacturers reported payments, led by Johnson & Johnson at 27.0% of the total. 2025 is the largest year on record at $169, 5.1 times the $33 reported in 2022. That places this record below the midpoint for dermatology clinicians in IA, where the typical reported total is $716.
Across 13 payments — averaging $28.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$99
- UCB, Inc.$97
- Pfizer$61
- Novartis$40
- Incyte Corporation$39
- Biofrontera Inc.$16
- plus $14 from 1 others
What the payments were for
- Food & beverage$19253%
- Education$17447%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 1 | $99 |
| UCB, Inc. | 3 | $97 |
| Pfizer | 4 | $61 |
| Novartis | 1 | $40 |
| Incyte Corporation | 2 | $39 |
| Biofrontera Inc. | 1 | $16 |
| Dermavant Sciences, Inc. | 1 | $14 |
How this compares
$366 in reported general payments places this provider in the 30th percentile of 92 dermatology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OtezlaApremilast | 11 | $62,693 |
| Clobetasol Propionate | 12 | $614 |
| Metronidazole | 15 | $559 |
| Ketoconazole | 27 | $500 |
| Hydrocortisone Valerate | 11 | $443 |
| Halobetasol Propionate | 12 | $440 |
| MethotrexateMethotrexate Sodium | 30 | $342 |
| Triamcinolone Acetonide | 25 | $298 |
| Fluticasone Propionate | 13 | $281 |
| ValacyclovirValacyclovir Hcl | 12 | $183 |
| Gabapentin | 11 | $63 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Waterloo
- Justin EllerbroekWaterloo$1K
- Roger CeilleyWest Des Moines$82K
- David KnutsonCedar Rapids$60K
- Scott GreenFort Dodge$56K
- Timothy AbrahamsonUrbandale$49K
- Ali JabbariIowa City$38K
- Ravindrakumar GangadhariahDavenport$20K
- Somaira NowsheenWaukee$15K
- Laura MyersAnkeny$7K
- Katrina SmithAnkeny$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.